ANTIBODIES TO A NOVEL FLAGELLIN (CBIR1) ADDS CLINICAL UTILITY TO THE DIAGNOSIS AND DIFFERENTIATION OF PEDIATRIC IBD

Marla Dubinsky

Western Regional Pediatric IBD Research Alliance, Los Angeles, CA

Cedars-Sinai Medical Center, Los Angeles, CA

Ling Mei

Cedars-Sinai Medical Center, Los Angeles, CA

Carol Landers

Cedars-Sinai Medical Center, Los Angeles, CA

Lirona Katzir

Western Regional Pediatric IBD Research Alliance, Los Angeles, CA

Sharmayne Farrior

Western Regional Pediatric IBD Research Alliance, Los Angeles, CA

Iwona Wrobel

Western Regional Pediatric IBD Research Alliance, Los Angeles, CA

Antonio Quiros

Western Regional Pediatric IBD Research Alliance, Los Angeles, CA

Ron Bahar

Western Regional Pediatric IBD Research Alliance, Los Angeles, CA

Ghassan Wahbeh

Western Regional Pediatric IBD Research Alliance, Los Angeles, CA

Bruce Grill

Western Regional Pediatric IBD Research Alliance, Los Angeles, CA

Gary Silber

Western Regional Pediatric IBD Research Alliance, Los Angeles, CA

Drew Kelts

Western Regional Pediatric IBD Research Alliance, Los Angeles, CA

Michelle Pietzak

Western Regional Pediatric IBD Research Alliance, Los Angeles, CA

Saied Dallazadeh

Western Regional Pediatric IBD Research Alliance, Los Angeles, CA

Eric Vasiliauskas

Western Regional Pediatric IBD Research Alliance, Los Angeles, CA

Charles Nelson

University of Alabama, Birmingham, AL

Robert Hershberg

Dendreon Corporation, Seattle, WA

Yang Huiying

Cedars-Sinai Medical Center, Los Angeles, CA

Jerome Rotter

Cedars-Sinai Medical Center, Los Angeles, CA

Stephan Targan

Cedars-Sinai Medical Center, Los Angeles, CA